Working… Menu

RIvoraxaban in Mitral Stenosis (RISE MS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03926156
Recruitment Status : Recruiting
First Posted : April 24, 2019
Last Update Posted : September 16, 2020
National Institute for Medical research and Development (NIMAD)
Abidi Pharmaceuticals
Information provided by (Responsible Party):
Rajaie Cardiovascular Medical and Research Center

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : May 22, 2021
Estimated Study Completion Date : June 23, 2021